PRE-TREATMENT SEX HORMONE LEVELS AND SPERM CONCENTRATION INFLUENCE MAGNITUDE OF RESPONSE TO CLOMIPHENE IN SUBFERTILE MEN

被引：0
|
作者：
Jiang, Tommy
Santamaria, Alvaro
Modiri, Neilufar
Zheng, Michael
Osadchiy, Vadim
Sigalos, John
Mills, Jesse
Eleswarapu, Sriram
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP31-17
引用
收藏
页码：E561 / E562
页数：2
相关论文
共 50 条
  • [31] Influence of pre-treatment nutrition and inflammation on immunotherapy response in non-small cell lung cancer
    Robinson, Lary A.
    Kim, Youngchul
    Buro, Acadia
    Hogue, Stephanie R.
    Bailey, Alexis
    DeNicola, Gina M.
    Pierce, Christine
    Umbarger, Mark
    Byrd, Doratha A.
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Pre-treatment erythropoietin levels cannot be used to predict individual response to epoetin alfa in anaemic cancer patients
    Littlewood, TJ
    Zagari, M
    Pallister, P
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 : S19 - S21
  • [33] Pre-treatment complement system serum protein levels predict pathological response to neoadjuvant chemoradiotherapy for esophageal cancer
    Maher, Stephen G.
    McDowell, Dermot T.
    Murphy, Sinead A.
    Collins, Ben C.
    Muldoon, Clan
    Gallagher, William M.
    Reynolds, John V.
    CANCER RESEARCH, 2011, 71
  • [34] Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models
    Smyczynska, Urszula
    Smyczynska, Joanna
    Hilczer, Maciej
    Stawerska, Renata
    Tadeusiewicz, Ryszard
    Lewinski, Andrzej
    ENDOCRINE CONNECTIONS, 2018, 7 (01): : 239 - 249
  • [35] Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level
    P. Chavassieux
    J.P. Roux
    R. Chapurlat
    Osteoporosis International, 2024, 35 : 653 - 658
  • [36] Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level
    Chavassieux, P.
    Roux, J. P.
    Chapurlat, R.
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (04) : 653 - 658
  • [37] Pre-treatment levels of miR-29b are associated with response to treatment and stage of fibrosis in patients with chronic hepatitis C [CHC]
    Sendi, Hossein
    Mehrab-Mohseni, Marjan
    Russo, Mark W.
    Zamor, Philippe J.
    Schmeltzer, Paul A.
    Steuerwald, Nury
    Parsons, Judith
    Clemens, Mark G.
    Kaplan, Keith
    Jacobs, W. Carl
    Ahrens, William A.
    Bonkovsky, Herbert L.
    HEPATOLOGY, 2015, 62 : 709A - 709A
  • [38] Evaluating COX 2 and apoptosis levels in pre-treatment biopsies as response predictors for rectal cancer undergoing neoadjuvant radiochemotherapy
    F. M. Smith
    E. Kay
    P. Crotty
    E. F. Gaffney
    R. B. Stephens
    M. J. Kennedy
    J. V. Reynolds
    Irish Journal of Medical Science, 2005, 174 (Suppl 1)
  • [39] Fluoxetine treatment of prepubertal male rats uniformly diminishes sex hormone levels and, in a subpopulation of animals, negatively affects sperm quality
    Ayala, Maria E.
    Gonzales, Ayari
    Olivarez, Rodrigo M.
    Aragon-Martinez, Andres
    REPRODUCTION FERTILITY AND DEVELOPMENT, 2018, 30 (10) : 1329 - 1341
  • [40] Does pre-treatment with micronized progesterone affect the ovarian response to a gonadotropin releasing hormone agonist flare-up protocol?
    Loutradis, D
    Stefanidis, K
    Drakakis, P
    Kallianidis, K
    El Sheikh, A
    Milingos, S
    Siskos, K
    Michalas, S
    GYNECOLOGICAL ENDOCRINOLOGY, 2003, 17 (02) : 101 - 106
12345